Literature DB >> 17208636

Cholesterol lowering in patients with CHD and metabolic syndrome.

Rob Butler, James Wainwright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17208636     DOI： 10.1016/S0140-6736(07)60025-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Generic and therapeutic substitutions in the UK: are they a good thing?

Authors:  Martin G Duerden; Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

2.  Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.

Authors:  Furio Colivicchi; Michele Massimo Gulizia; Laura Franzini; Giuseppe Imperoli; Lorenzo Castello; Alessandro Aiello; Claudio Ripellino; Nazarena Cataldo
Journal:  Adv Ther       Date:  2016-09-26       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.